Healthcare Services

Global Multiomics Services Market Report 2026–2035 Highlighting Expansion Outlook and Forecast Opportunities

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Multiomics Services Market In 2026 And What Value Is Projected For 2030?

The multiomics services market size has experienced significant expansion recently. It is forecast to grow from $1.42 billion in 2025 to $1.71 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 20.4%. This historical growth can be attributed to increased genomics and proteomics research efforts, the rise in funding for academic and clinical research, broader access to high-throughput sequencing technologies, growing partnerships among research institutions, and continuous improvements in bioinformatics tools.

The multiomics services market is projected to experience substantial expansion over the coming years, with its size anticipated to reach $3.56 billion by 2030, driven by a compound annual growth rate (CAGR) of 20.1%. This growth during the forecast period can be attributed to the increasing integration of precision medicine approaches, growing pharmaceutical sector investments in systems biology, the broadening scope of multiomics applications in drug discovery, the increasing utilization of AI for interpreting biological data, and the rising need for personalized therapeutic solutions. Prominent trends observed in the forecast period are expected to encompass the wider adoption of integrated multiomics analysis platforms, a growing demand for single-cell multiomics services, increased reliance on data-driven biological insights, the expansion of cloud-based omics data integration, and a sharpened focus on translational research applications.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27355&type=smp

What Drivers Are Influencing The Multiomics Services Market?

The increasing embrace of personalized medicine is set to fuel the expansion of the multiomics services market moving forward. Personalized medicine is defined as a medical model that utilizes insights into an individual’s genes and lifestyle environment to customize treatments and healthcare according to their unique requirements. This heightened adoption of personalized medicine results from people’s preference for health technologies that offer real-time monitoring and treatment plans specifically tailored to their distinct biology. Multiomics services contribute to advancing personalized medicine by integrating a variety of biological data, such as genomics, transcriptomics, proteomics, and metabolomics, to build a thorough understanding of an individual’s health profile, thereby enabling personalized diagnosis, treatment, and disease prevention strategies. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a significant increase from the 12 approved in 2022. Thus, the growing adoption of personalized medicine is propelling the development of the multiomics services market.

What Are The Key Segments Of The Multiomics Services Market?

The multiomics services market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Application: Biomarker Discovery, Drug Discovery And Development, Synthetic Biology, Other Applications

3) By End Users: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics Services, Single-Cell Transcriptomics Services, Single-Cell Proteomics Services, Single-Cell Epigenomics Services

2) By Bulk Multiomics: Genomics And Transcriptomics Integration Services, Genomics And Proteomics Integration Services, Transcriptomics And Proteomics Integration Services, Epigenomics And Transcriptomics Integration Services

What Trends Are Advancing Progress In The Multiomics Services Market?

Leading companies within the multiomics services market are prioritizing the development of innovative methods, such as 3D genome mapping, to improve understanding of gene regulation, disease mechanisms, and personalized treatment strategies. 3D genome mapping involves determining the three-dimensional spatial arrangement of the genome inside a cell’s nucleus. For example, in January 2025, Enhanc3D Genomics, a UK-based biotechnology company, unveiled a collection of 3D multi-omics solutions designed to accelerate and enhance the precision of drug discovery. Its distinctive features include integrating genome-wide regulatory interaction data with multi-omics profiles in a single assay, thereby providing comprehensive insights into gene regulation. The company’s proprietary Promoter Capture Hi-C technology allows for the accurate mapping of long-range interactions between regulatory elements and target genes, including those found in non-coding regions. The platform’s modular design, incorporating GenLinkConnect, GenLinkResponse, and GenLinkProfile, supports SNP-to-gene linkage, drug response analysis, and cell-specific regulatory profiling, respectively. Moreover, the GenLinkHub software presents an intuitive interface for 3D visualization, data management, and quality control, significantly improving researchers’ capacity to interpret complex datasets and expedite drug discovery.

Who Are The Leading Companies Operating In The Multiomics Services Market?

Major companies operating in the multiomics services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, QIAGEN NV, Azenta Inc., BGI Group, 10x Genomics Inc., BioLegend Inc., Oxford Nanopore Technologies Plc, NanoString Technologies Inc., Pacific Biosciences Inc., Metware Biotechnology Inc., Source BioScience Limited, CD Genomics Inc., Psomagen Inc., Creative Proteomics, Sapient Bioanalytics LLC, Dalton Bioanalytics Inc., Clinical Microbiomics A/S.

Read the full multiomics services market report here:

https://www.thebusinessresearchcompany.com/report/multiomics-services-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Multiomics Services Market?

North America was the largest region in the multiomics services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Multiomics Services Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27355&type=smp

Browse Through More Reports Similar to the Global Multiomics Services Market 2026, By The Business Research Company

Genomics Global Market Report

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Bioinformatics Global Market Report

https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report

Computational Biology Global Market Report

https://www.thebusinessresearchcompany.com/report/computational-biology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795